{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:00Z","timestamp":1787022420446,"version":"build-2736575974"},"reference-count":57,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0347","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:11:28Z","timestamp":1727201488000},"page":"115-122","source":"Crossref","is-referenced-by-count":2,"title":["Transition from hypothyroidism to Graves\u2019 disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature"],"prefix":"10.1507","volume":"72","author":[{"given":"Koichiro","family":"Mizuochi","sequence":"first","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hiromatsu","sequence":"additional","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"},{"name":"Diabetes, Thyroid, and Endocrine Center, Shin Koga Hospital, Kurume 830-8577, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Sonezaki","sequence":"additional","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Adachi","sequence":"additional","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Kato","sequence":"additional","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Wada","sequence":"additional","affiliation":[{"name":"Diabetes Center, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kurose","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kurume University Medical Center, Kurume 839-0863, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y (2014) Graves\u2019 ophthalmopathy: epidemiology and natural history. Intern Med 53: 353\u2013360.","DOI":"10.2169\/internalmedicine.53.1518"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kozaki A, Inoue R, Komoto N, Maeda T, Inoue Y, et al. (2010) Proptosis in dysthyroid ophthalmopathy: a case series of 10,931 Japanese cases. Optom Vis Sci 87: 200\u2013204.","DOI":"10.1097\/OPX.0b013e3181ce5702"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Potvin ARGG, Pakdel F, Saeed P (2023) Dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg 39: S65\u2013S80.","DOI":"10.1097\/IOP.0000000000002555"},{"key":"4","unstructured":"4 Japan Thyroid Association, Japan Endocrine Society (2020) Treatment Guide for Thyroid-Associated Ophthalmopathy. Medical Review, Tokyo, Japan (In Japanese)."},{"key":"5","unstructured":"5 Japan Thyroid Association (2023) Diagnostic Criteria and Treatment Guidelines for Thyroid Eye Disease. https:\/\/www.japanthyroid.jp\/doctor\/img\/basedou03_2023.pdf accessed on June 21, 2024 (In Japanese)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, et al. (2016) The 2016 European thyroid association\/European group on Graves\u2019 orbitopathy guidelines for the Management of Graves\u2019 Orbitopathy. Eur Thyroid J 5: 9\u201326.","DOI":"10.1159\/000443828"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, et al. (2021) The 2021 European group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185: G43\u2013G67.","DOI":"10.1530\/EJE-21-0861"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Hiromatsu Y, Kojima K, Ishisaka N, Tanaka K, Sato M, et al. (1992) Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy. Thyroid 2: 299\u2013305.","DOI":"10.1089\/thy.1992.2.299"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kasagi K, Konishi J, Iida Y, Mori T, Torizuka K (1986) Changes in thyroid-stimulating and TSH-binding inhibitory activities in a patient who developed hyperthyroidism due to Graves\u2019 disease following primary hypothyroidism. Clin Endocrinol (Oxf) 25: 519\u2013525.","DOI":"10.1111\/j.1365-2265.1986.tb03604.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Takeda K, Takamatsu J, Kasagi K, Sakane S, Ikegami Y, et al. (1988) Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies. Clin Endocrinol (Oxf) 28: 341\u2013344.","DOI":"10.1111\/j.1365-2265.1988.tb03664.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Cho BY, Shong YK, Lee HK, Koh CS, Min HK (1989) Graves\u2019 hyperthyroidism following primary hypothyroidism: sequential changes in various activities of thyrotropin receptor antibodies. Acta Endocrinol (Copenh) 120: 447\u2013450.","DOI":"10.1530\/acta.0.1200447"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, et al. (1990) Graves\u2019 disease following hypothyroidism due to Hashimoto\u2019s disease: Studies of eight cases. Clin Endocrinol (Oxf) 33: 687\u2013698.","DOI":"10.1111\/j.1365-2265.1990.tb03906.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M (1992) Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyperthyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 36: 211\u2013214.","DOI":"10.1111\/j.1365-2265.1992.tb00960.x"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Kasagi K, Hidaka A, Endo K, Miyamoto S, Takeuchi R, et al. (1993) Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report. Thyroid 3: 315\u2013318.","DOI":"10.1089\/thy.1993.3.315"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Umena S, Takano T, Iijima T, Hidaka Y, Yagoro A, et al. (1995) A case of repeated painless thyroiditis followed by Graves\u2019 disease. Endocr J 42: 821\u2013826.","DOI":"10.1507\/endocrj.42.821"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yamasaki H, Takeda K, Nakauchi Y, Suehiro T, Hashimoto K (1995) Hypothyroidism preceding hyperthyroidism in a patient with continuously positive thyroid stimulating antibody. Intern Med 34: 247\u2013250.","DOI":"10.2169\/internalmedicine.34.247"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Bando Y, Nagai Y, Ushiogi Y, Toya D, Tanaka N, et al. (1999) Development of Graves\u2019 hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis. Thyroid 9: 183\u2013187.","DOI":"10.1089\/thy.1999.9.183"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Chung YH, Ou HY, Wu TJ (2004) Development of hyperthyroidism following primary hypothyroidism: A case report. Kaohsiung J Med Sci 20: 188\u2013191.","DOI":"10.1016\/S1607-551X(09)70105-6"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Lu R, Burman KD, Jonklaas J (2005) Transient Graves\u2019 hyperthyroidism during pregnancy in a patient with Hashimoto\u2019s hypothyroidism. Thyroid 15: 725\u2013729.","DOI":"10.1089\/thy.2005.15.725"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ohye H, Nishihara E, Sasaki I, Kubota S, Fukata S, et al. (2006) Four cases of Graves\u2019 disease which developed after painful Hashimoto\u2019s thyroiditis. Intern Med 45: 385\u2013389.","DOI":"10.2169\/internalmedicine.45.1506"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Gola M, Doga M, Mazziotti G, Bonadonna S, Giustina (2006) Development of Graves\u2019 hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto\u2019s hypothyroidism. J Endocrinol Invest 29: 288\u2013290.","DOI":"10.1007\/BF03345556"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kamath C, Young S, Kabelis K, Sanders J, Adlan MA, et al. (2012) Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto\u2019s who developed Graves\u2019 disease and pretibial myxoedema. Clin Endocrinol 77: 465\u2013470.","DOI":"10.1111\/j.1365-2265.2012.04397.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Takasu N, Matsushita M (2012) Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) over 10 years in 34 TSBAb-Positive patients with hypothyroidism and in 98 TSAb-Positive Graves\u2019 Patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-positive patients. J Thyroid Res 2012: 182176.","DOI":"10.1155\/2012\/182176"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Fan W, Tandon P, Krishnamurthy M (2014) Oscillating hypothyroidism and hyperthyroidism\u2014A case-based review. J Community Hosp Intern Med Perspect 4: 25734.","DOI":"10.3402\/jchimp.v4.25734"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Furqan S, Haque NU, Islam N (2014) Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res Notes 7: 489.","DOI":"10.1186\/1756-0500-7-489"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Aversa T, Lombardo F, Corrias A, Salerno M, De Luca F, et al. (2014) In young patients with Turner or Down syndrome, Graves\u2019 disease presentation is often preceded by Hashimoto\u2019s thyroiditis. Thyroid 24: 744\u2013747.","DOI":"10.1089\/thy.2013.0452"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bishay RH, Chen RC (2016) Hashimoto\u2019s thyroiditis and Graves\u2019 disease in one patient: the extremes of thyroid dysfunction associated with interferon treatment. Case Rep Endocrinol 2016: 6029415.","DOI":"10.1155\/2016\/6029415"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Pak S, Valencia D, Fershko A (2017) Transformation of Hashimoto thyroiditis to Graves\u2019 disease. Res Rev Insights 1: 1\u20132.","DOI":"10.15761\/RRI.1000117"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Kempegowda P, Nayak AU (2017) Thyrotoxicosis in patients with hypothyroidism is not just overtreatment. BMJ Case Rep 2017: bcr-2017-221061.","DOI":"10.1136\/bcr-2017-221061"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Ahmad E, Hafeez K, Arshad MF, Isuga J, Vrettos A (2018) Hypothyroidism conversion to hyperthyroidism: it\u2019s never too late. Endocrinol Diabetes Metab Case Rep 2018: 18-0047.","DOI":"10.1530\/EDM-18-0047"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Clifford L, Wakil A (2018) Conversion of primary hypothyroidism to hyperthyroidism: a case report. J ASEAN Fed Endocr Soc 33: 190\u2013193.","DOI":"10.15605\/jafes.033.02.12"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Gonzalez-Aguilera B, Betea D, Lutteri L, Cavalier E, Geenen V, et al. (2018) Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients. Arch Endocrinol Metab 62: 609\u2013614.","DOI":"10.20945\/2359-3997000000086"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ekpebegh C, Elmezughi K, Mtingi L (2019) Graves\u2019 disease following hypothyroidism due to Hashimoto\u2019s thyroiditis in a black South African lady: A case report. Pan Afr Med J 32: 186\u2013189.","DOI":"10.11604\/pamj.2019.32.186.18713"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kafrouni Gerges AR, Clark SN, Shawa H (2019) Hypothyroidism to hyperthyroidism: an immunological pendulum swing from two extreme poles\u2014a case series. BMJ Case Rep 12: e227445.","DOI":"10.1136\/bcr-2018-227445"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Trummer C, Schwetz V, Aberer F, Pandis M, Lerchbaum E, et al. (2019) Rapid changes of thyroid function in a young woman with autoimmune thyroid disease. Med Princ Pract 28: 397\u2013400.","DOI":"10.1159\/000499754"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Watari J, Jassil N (2020) Conversion of hypothyroidism to hyperthyroidism: a rare clinical phenomenon. AACE Clin Case Rep 6: e279\u2013e281.","DOI":"10.4158\/ACCR-2020-0076"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Sukik A, Mohamed S, Habib MB, Sardar S, Tanous B, et al. (2020) The unusual late-onset Graves\u2019 disease following Hashimoto\u2019s related hypothyroidism: a case report and literature rview. Case Rep Endocrinol 2020: 5647273.","DOI":"10.1155\/2020\/5647273"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Jadhav R, Alberawi M, Gupta K (2021) Graves\u2019 disease: a rare fate of Hashimoto\u2019s thyroiditis. World J Nucl Med 20: 102\u2013104.","DOI":"10.4103\/wjnm.WJNM_34_20"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Maksoud R, Maksoud N, Wannous L, Almousa S (2021) Switching of Hashimoto thyroiditis into Graves\u2019 disease: a case report and literature review. Dis Diagn 10: 82\u201385.","DOI":"10.34172\/ddj.2021.16"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Arshad I, Zahra T, Vargas-Jerez J (2022) New-onset Graves\u2019 disease in the background of Hashimoto\u2019s thyroiditis: spectrums of the same disease with changing autoantibodies. Cureus 14: e28296.","DOI":"10.7759\/cureus.28296"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Asano M, Kenzaka T (2022) Guillain-Barr\u00e9 syndrome with transition from Hashimoto\u2019s to Graves\u2019 disease: a case report. BMC Endocr Disord 22: 157.","DOI":"10.1186\/s12902-022-01067-7"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Daramjav N, Takagi J, Iwayama H, Uchino K, Inukai D, et al. (2023) Autoimmune thyroiditis shifting from Hashimoto\u2019s thyroiditis to Graves\u2019 disease. Medicina (Kaunas) 59: 757.","DOI":"10.3390\/medicina59040757"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Stancu AM, Alexandrescu D, Badiu C (2024) Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves\u2019 disease. Hormones (Athens) 23: 107\u2013111.","DOI":"10.1007\/s42000-023-00496-w"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ta\u015fkald\u0131ran I, Altay FP, Bozku\u015f Y, \u0130yidir \u00d6T, Nar A, et al. (2023) A case report of conversion from Hashimoto\u2019s thyroiditis to Graves\u2019 disease in type 1 diabetic patient following the COVID-19 vaccination. Endocr Metab Immune Disord Drug Targets 23: 405\u2013409.","DOI":"10.2174\/1871530322666220616104058"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Vassallo A, Ferrari F, di Filippo L, Giustina A, Loli P (2024) Transition from Hashimoto thyroiditis to Graves\u2019s disease: an unpredictable change? Endocrine 84: 541\u2013548.","DOI":"10.1007\/s12020-023-03634-x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Alnahdi H (2024) The thyroid swing: a patient\u2019s journey from hypothyroidism to hyperthyroidism. Cureus 16: e52598.","DOI":"10.7759\/cureus.52598"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Kelly DA, Turbin RE (2024) Rapid response of thyroid eye disease, peripheral edema, and acropathy to teprotumumab infusion. Am J Ophthalmol Case Rep 34: 102031.","DOI":"10.1016\/j.ajoc.2024.102031"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Kamijo K (2024) Shift in dominance from blocking to stimulating type of thyrotropin receptor antibodies, resulting in conversion from hypothyroidism to hyperthyroidism during late pregnancy. Intern Med 63: 521\u2013526.","DOI":"10.2169\/internalmedicine.1929-23"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49 McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23: 14\u201324.","DOI":"10.1089\/thy.2012.0374"},{"key":"50","unstructured":"50 Kozaki A (2021) Treatment guide for thyroid eye disease\u2014practical treatment of ophthalmopathy from the viewpoint of an ophthalmologist\u2014. Journal of Japan Thyroid Assoiation 23: 62\u201368 (In Japanese)."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Tagami M, Honda S, Azumi A (2020) Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy. BMC Ophthalmol 20: 30.","DOI":"10.1186\/s12886-020-1314-8"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Eguchi H, Tani J, Hirao S, Tsuruta M, Tokubuchi I, et al. (2015) Liver dysfunction associated with intravenous methylprednisolone pulse therapy in patients with Graves\u2019 orbitopathy. Int J Endocrinol 2015: 835979.","DOI":"10.1155\/2015\/835979"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, et al. (2022) Management of thyroid eye disease: a consensus statement by the American thyroid association and the European thyroid association. Thyroid 32: 1439\u20131470.","DOI":"10.1089\/thy.2022.0251"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, et al. (2017) Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med 376: 1748\u20131761.","DOI":"10.1056\/NEJMoa1614949"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, et al. (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382: 341\u2013352.","DOI":"10.1056\/NEJMoa1910434"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Sears CM, Wang Y, Bailey LA, Turbin R, Subramanian PS, et al. (2021) Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: a multicenter study. Am J Ophthalmol Case Rep 23: 101111.","DOI":"10.1016\/j.ajoc.2021.101111"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Tamhankar MA, Pradeep T, Chen Y, Brice\u00f1o CA (2024) Real-world experience with Teprotumumab in patients with dysthyroid optic neuropathy. J Neuroophthalmol 44: 74\u201379.","DOI":"10.1097\/WNO.0000000000001994"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0347\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T22:35:43Z","timestamp":1736548543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0347\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0347","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0347"}}